Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Diclofenac Sodium, and what generic Diclofenac Sodium alternatives are available?

Diclofenac Sodium is a drug marketed by Apotex Inc, Glenmark Pharms Ltd, Dexcel Ltd, Falcon Pharms, Actavis Elizabeth, Amneal Pharms, Taro, Teva, Sandoz Inc, Lupin Ltd, Pliva, Tolmar, Akorn, Watson Labs Inc, Mylan, Rising Pharms Inc, Teva Pharms, Unique Pharm Labs, Teligent Pharma Inc, Sandoz, Novel Labs Inc, Mylan Pharms Inc, Altaire Pharms Inc, Carlsbad, Allied Pharma Inc, Roxane, Bausch And Lomb, Vpna, Actavis Mid Atlantic, Twi Pharms Inc, Exela Holdings, and Actavis Labs Fl Inc. and is included in forty-one NDAs.

The generic ingredient in DICLOFENAC SODIUM is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.

Summary for Tradename: DICLOFENAC SODIUM

Suppliers / Packagers: see list71
Bulk Api Vendors: see list70
Clinical Trials: see list981
Patent Applications: see list6,198
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DICLOFENAC SODIUM at DailyMed

Pharmacology for Tradename: DICLOFENAC SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
diclofenac sodium
TABLET, DELAYED RELEASE;ORAL074391-001Jun 29, 1995DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
diclofenac sodium
TABLET, DELAYED RELEASE;ORAL075281-002Feb 12, 2002ABRXNoNo► Subscribe► Subscribe
diclofenac sodium
GEL;TOPICAL206298-001Apr 28, 2016ABRXNoNo► Subscribe► Subscribe
diclofenac sodium
TABLET, EXTENDED RELEASE;ORAL075492-001Feb 11, 2000ABRXNoNo► Subscribe► Subscribe
Exela Holdings
diclofenac sodium; misoprostol
TABLET, DELAYED RELEASE;ORAL200540-001Mar 14, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus